Biotech Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy October 23, 2026
Biotech Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3 October 23, 2026
Health Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA October 23, 2026
Biotech ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial October 23, 2026
Biotech ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026 October 23, 2026
Search
press release
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
October 23, 2026
